| Patient | Ella Fitzgerald |
|---|---|
| Date of birth | 1917-04-25 |
| Identifiers | MRN HR-ML029-SYN-TD; SSN (made up) 000-29-3640 |
| Document date | 1987-05-11 |
| Author | Odessa Whitlow, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for new patient visit: diabetes with calf pain on walking, low glucose after late shows, eye and foot examinations, and cardiovascular risk. [S]
Hemoglobin A1c: 8.6% (high); Sodium: 139 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 0.92 mg/dL; eGFR: 67 mL/min/1.73 m²; Glucose: 168 mg/dL (high); Urine albumin-creatinine ratio: 18 mg/g; Total cholesterol: 164 mg/dL; LDL cholesterol: 92 mg/dL; HDL cholesterol: 44 mg/dL (low); Triglycerides: 140 mg/dL; ALT: 22 U/L; AST: 24 U/L; Hemoglobin: 12.4 g/dL; Vitamin B12: 386 pg/mL; Ankle-brachial index, right: 0.62 (low); Ankle-brachial index, left: 0.74 (low); Toe-brachial index, right: 0.46 (low); Toe-brachial index, left: 0.55 (low); Best-corrected visual acuity, right eye (ETDRS letters): 64 (low); Best-corrected visual acuity, left eye (ETDRS letters): 81. [S]
Change since baseline:
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1987-05-11 | Body height | 165 | cm | S |
| 1987-05-11 | Body weight | 84 | kg | S |
| 1987-05-11 | Body mass index (BMI) [Ratio] | 30.9 | kg/m2 | S |
| 1987-05-11 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1987-05-11 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1987-05-11 | Heart rate | 62 | /min | S |
| 1987-05-11 | Respiratory rate | 16 | /min | S |
| 1987-05-11 | Body temperature | 36.6 | Cel | S |
| 1987-05-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1987-05-11 | Hemoglobin A1c/Hemoglobin.total in Blood | 8.6 | % | Below 5.7% is normal; her individualized goal is below 7.5% | High | S |
| 1987-05-11 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1987-05-11 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1987-05-11 | Creatinine [Mass/volume] in Serum or Plasma | 0.92 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1987-05-11 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1982)/1.73 sq M | 67 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1987-05-11 | Glucose [Mass/volume] in Serum or Plasma | 168 | mg/dL | 70-99 mg/dL | High | S |
| 1987-05-11 | Albumin/Creatinine [Mass Ratio] in Urine | 18 | mg/g | <=30 mg/g | Normal | S |
| 1987-05-11 | Cholesterol [Mass/volume] in Serum or Plasma | 164 | mg/dL | <=199 mg/dL | Normal | S |
| 1987-05-11 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 92 | mg/dL | Her goal with coronary and peripheral artery disease is below 55 mg/dL | Normal | S |
| 1987-05-11 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=50 mg/dL | Low | S |
| 1987-05-11 | Triglyceride [Mass/volume] in Serum or Plasma | 140 | mg/dL | <=149 mg/dL | Normal | S |
| 1987-05-11 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 7-35 U/L | Normal | S |
| 1987-05-11 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 10-35 U/L | Normal | S |
| 1987-05-11 | Hemoglobin [Mass/volume] in Blood | 12.4 | g/dL | 11.6-15 g/dL | Normal | S |
| 1987-05-11 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 386 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1987-05-11 | Ankle-brachial index | 0.62 | {ratio} | 1.00 to 1.40 normal; 0.91 to 0.99 borderline; 0.90 or below abnormal | Low | S |
| 1987-05-11 | Ankle-brachial index | 0.74 | {ratio} | 1.00 to 1.40 normal; 0.91 to 0.99 borderline; 0.90 or below abnormal | Low | S |
| 1987-05-11 | Toe brachial index - right | 0.46 | {ratio} | Above 0.70 normal | Low | S |
| 1987-05-11 | Toe brachial index - left | 0.55 | {ratio} | Above 0.70 normal | Low | S |
| 1987-05-11 | Visual acuity best corrected Right eye by ETDRS eye chart | 64 | {letters} | 85 letters is about 20/20; 80 about 20/25; 65 about 20/50 | Low | S |
| 1987-05-11 | Visual acuity best corrected Left eye by ETDRS eye chart | 81 | {letters} | 85 letters is about 20/20; 80 about 20/25; 65 about 20/50 | Normal | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin 1000 mg oral tablet, one tablet by mouth twice daily with meals | One tablet by mouth twice daily with breakfast and the evening meal | Oral route | 1977-03-01 | active | S |
| Glipizide 10 mg oral tablet, one tablet by mouth twice daily before meals | One tablet by mouth twice daily before breakfast and the evening meal | Oral route | 1982-09-01 to 1987-05-11 | completed | S |
| Insulin glargine 100 units/mL pen, 30 units under the skin at bedtime | 30 units at bedtime | Subcutaneous route | 1984-04-01 to 1987-05-11 | completed | S |
| Insulin glargine 100 units/mL pen, 24 units under the skin each morning | 24 units each morning, at the same clock time on tour, with written time-zone adjustments | Subcutaneous route | 1987-05-11 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1986-06-02 to 1987-05-11 | completed | S |
| Atorvastatin 80 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1987-05-11 | active | S |
| Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1986-06-02 | active | S |
| Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1986-06-02 | active | S |
| Empagliflozin 10 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning; hold on days she cannot eat or drink normally and before surgery | Oral route | 1987-05-11 | active | S |
| Glucagon 3 mg nasal powder, one spray into one nostril for a severe low glucose | One spray into one nostril if she cannot safely swallow during a low glucose; may repeat once after 15 minutes with a new device; call 911 | Nasal route | 1987-05-11 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Type 2 diabetes mellitus with peripheral artery disease: cramping in both calves after about one and a half blocks of walking, worse on the right, easing within minutes of rest; no rest pain, wounds, or color change. Resting ankle-brachial index 0.62 right and 0.74 left, toe-brachial index 0.46 and 0.55; dorsalis pedis and posterior tibial pulses absent on the right and faint on the left. A1c 8.6% on metformin, glipizide and glargine, with low glucose readings (to 52 mg/dL) after late performances. Foot: protective sensation intact to the 10-g monofilament at all sites and to vibration; callus under the second metatarsal heads; hammer toes of the second and third toes; no ulcer (IWGDF risk category 2). Synthetic modern episode linked to her documented diabetes and its circulatory complications | active | confirmed | E11.51 | S — Synthetic modern diagnosis; the type of diabetes was not made public and is synthetic. |
| Moderate nonproliferative diabetic retinopathy with center-involving diabetic macular edema in the right eye (best-corrected acuity 64 letters, about 20/50) and moderate nonproliferative retinopathy without macular edema in the left eye (81 letters); lens implants in both eyes from earlier cataract surgery. Synthetic modern episode linked to her documented diabetic eye problems | active | confirmed | E11.3311 | S — Synthetic modern eye diagnosis on retinal imaging and optical coherence tomography in the clinic; the left eye is described in the display. |
| Coronary artery disease after five-vessel coronary bypass surgery last year, with an intensive care stay; no angina now; on aspirin, a statin, and metoprolol. Synthetic modern episode linked to her documented heart surgery | active | confirmed | I25.10 | S — Synthetic modern coding of her documented heart surgery; bypass grafts are described in the display. |